4'-(9-acridinylamino)methanesulfon-o-anisidide has been researched along with hoe 33342 in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
Bell, SM; Dee, A; Smith, PJ; Sykes, H | 1 |
2 other study(ies) available for 4'-(9-acridinylamino)methanesulfon-o-anisidide and hoe 33342
Article | Year |
---|---|
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Involvement of DNA topoisomerase II in the selective resistance of a mammalian cell mutant to DNA minor groove ligands: ligand-induced DNA-protein crosslinking and responses to topoisomerase poisons.
Topics: Amsacrine; Animals; Anthramycin; Benzimidazoles; Benzodiazepinones; Cell Line; Cell Survival; Distamycins; DNA; DNA Damage; DNA Topoisomerases, Type II; Doxorubicin; Drug Resistance; Intercalating Agents; Ligands; Mice; Mitoxantrone; Mutation; Nuclear Proteins; Pyrroles | 1990 |